- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
932
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
932 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
7846 | JP¥4,451.00 | 3.3% | -10.7% | JP¥175.3b | JP¥5,400.00 | PE13.5x | E9.7% | 2.4% | Commercial Services | ||
OC | US$157.76 | -1.2% | 12.8% | US$13.6b | US$186.68 | PE13x | E16.7% | 1.5% | Capital Goods | ||
EVTC | US$32.94 | -2.0% | -13.6% | US$2.1b | US$37.40 | PE30.4x | E21.4% | 0.6% | Diversified Financials | ||
ALNSE | €29.20 | 1.0% | 16.8% | €92.7m | €27.80 | PE22.4x | E20.2% | 0.8% | Capital Goods | ||
7467 | JP¥3,395.00 | -2.9% | -18.7% | JP¥34.4b | n/a | PE8.6x | E23.8% | 5.4% | Tech | ||
EXENS | €21.00 | 1.9% | n/a | €1.1b | €26.90 | PE545.6x | E32.2% | n/a | Capital Goods | ||
GRF | €9.23 | -6.4% | -29.8% | €5.8b | €17.72 | PE37.9x | E28.3% | n/a | Pharmaceuticals & Biotech | ||
TRIS3 | R$4.63 | -2.3% | -19.8% | R$852.3m | R$8.67 | PE6.6x | E20.4% | 1.5% | Consumer Durables | ||
ART | €6.25 | 1.6% | 61.1% | €356.0m | €6.97 | PE29.5x | E29.7% | 1.7% | Capital Goods | ||
6640 | JP¥1,460.00 | -9.7% | -10.4% | JP¥28.3b | JP¥2,150.00 | PE25.8x | E27.8% | 2.7% | Tech | ||
FEYTECH | RM 0.89 | -1.7% | n/a | RM 754.7m | RM 1.10 | PE17.1x | E20.4% | n/a | Automobiles | ||
AZN | UK£124.06 | -5.9% | 16.1% | UK£192.3b | UK£140.77 | PE39.1x | E16.5% | 1.8% | Pharmaceuticals & Biotech | ||
NAPA | NOK 32.50 | 3.2% | 215.5% | NOK 3.2b | NOK 36.82 | PS13.3x | E107.5% | n/a | Tech | ||
PRGS | US$57.62 | -0.9% | -0.8% | US$2.4b | US$64.33 | PE33.6x | E21.2% | 1.2% | Software | ||
300896 | CN¥137.98 | -1.1% | -56.2% | CN¥41.6b | CN¥264.39 | PE20.6x | E22.4% | 0% | Pharmaceuticals & Biotech | ||
KSPI | US$122.92 | -2.1% | n/a | US$23.4b | US$152.54 | PE11.9x | E22.5% | 5.8% | Diversified Financials | ||
LITI | SEK 8.30 | 4.0% | -5.7% | SEK 137.7m | n/a | PE1199.8x | E111.3% | n/a | Software | ||
1407 | JP¥2,541.00 | -4.7% | -17.0% | JP¥96.7b | JP¥4,078.00 | PE17.9x | E22.2% | 2.2% | Capital Goods | ||
SOFF | NOK 33.34 | -4.7% | 39.6% | NOK 3.1b | n/a | PB1.8x | E126.2% | 0% | Energy | ||
3697 | JP¥11,820.00 | -10.7% | -57.1% | JP¥207.1b | JP¥20,557.00 | PE37.4x | E32.5% | n/a | Software | ||
MEX | UK£0.51 | 0% | -28.7% | UK£19.7m | n/a | PB6.8x | E79.5% | n/a | Consumer Services | ||
7379 | JP¥651.00 | -2.0% | -28.0% | JP¥5.4b | n/a | PE24x | E33.5% | n/a | Commercial Services | ||
HMC | AU$7.84 | -5.8% | 46.0% | AU$3.0b | AU$7.82 | PB2.4x | E19.1% | 1.5% | Real Estate | ||
MILDEF | SEK 82.50 | -0.1% | 6.5% | SEK 3.3b | SEK 90.50 | PE75.9x | E47.0% | 0.6% | Capital Goods |